应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HCWB HCW Biologics Inc.
已收盘 07-16 16:00:00 EDT
4.79
+0.43
+9.86%
盘后
4.50
-0.29
-6.05%
19:22 EDT
最高
4.79
最低
4.30
成交量
3.23万
今开
4.36
昨收
4.36
日振幅
11.24%
总市值
765.06万
流通市值
461.98万
总股本
159.72万
成交额
14.66万
换手率
3.35%
流通股本
96.45万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Hcw Biologics Inc.盘中异动 股价大涨6.29%报4.63美元
市场透视 · 07-16 16:14
Hcw Biologics Inc.盘中异动 股价大涨6.29%报4.63美元
Hcw Biologics Inc.盘中异动 大幅拉升6.31%
市场透视 · 07-09
Hcw Biologics Inc.盘中异动 大幅拉升6.31%
Hcw Biologics Inc.6月11日成交额为12.34万美元
市场透视 · 06-12
Hcw Biologics Inc.6月11日成交额为12.34万美元
Hcw Biologics Inc.6月10日成交额为24.75万美元
市场透视 · 06-11
Hcw Biologics Inc.6月10日成交额为24.75万美元
Hcw Biologics Inc.6月9日成交额为18.86万美元
市场透视 · 06-10
Hcw Biologics Inc.6月9日成交额为18.86万美元
Hcw Biologics Inc.6月5日成交额为27.34万美元
市场透视 · 06-06
Hcw Biologics Inc.6月5日成交额为27.34万美元
Hcw Biologics Inc.6月4日成交额为78.63万美元
市场透视 · 06-05
Hcw Biologics Inc.6月4日成交额为78.63万美元
Hcw Biologics Inc.6月3日成交额为21.07万美元
市场透视 · 06-04
Hcw Biologics Inc.6月3日成交额为21.07万美元
Hcw Biologics Inc.6月2日成交额为18.31万美元
市场透视 · 06-03
Hcw Biologics Inc.6月2日成交额为18.31万美元
Hcw Biologics Inc.5月30日成交额为198.69万美元
市场透视 · 05-31
Hcw Biologics Inc.5月30日成交额为198.69万美元
Hcw Biologics Inc.5月29日成交额为47.21万美元
市场透视 · 05-30
Hcw Biologics Inc.5月29日成交额为47.21万美元
Hcw Biologics Inc.5月27日成交额为84.07万美元
市场透视 · 05-28
Hcw Biologics Inc.5月27日成交额为84.07万美元
Hcw Biologics Inc.5月23日成交额为63.38万美元
市场透视 · 05-24
Hcw Biologics Inc.5月23日成交额为63.38万美元
Hcw Biologics Inc.2025财年第一财季实现净利润-2.20百万美元,同比增加70.55%
市场透视 · 05-23
Hcw Biologics Inc.2025财年第一财季实现净利润-2.20百万美元,同比增加70.55%
Hcw Biologics Inc.5月21日成交额为51.81万美元
市场透视 · 05-22
Hcw Biologics Inc.5月21日成交额为51.81万美元
Hcw Biologics Inc.5月20日成交额为199.66万美元
市场透视 · 05-21
Hcw Biologics Inc.5月20日成交额为199.66万美元
Hcw Biologics Inc.盘中异动 大幅拉升5.13%报9.01美元
市场透视 · 05-20
Hcw Biologics Inc.盘中异动 大幅拉升5.13%报9.01美元
Hcw Biologics Inc.5月19日成交额为218.29万美元
市场透视 · 05-20
Hcw Biologics Inc.5月19日成交额为218.29万美元
Hcw Biologics Inc.盘中异动 早盘快速下挫5.03%
市场透视 · 05-19
Hcw Biologics Inc.盘中异动 早盘快速下挫5.03%
Hcw Biologics Inc.盘中异动 早盘大幅上涨5.37%
市场透视 · 05-16
Hcw Biologics Inc.盘中异动 早盘大幅上涨5.37%
加载更多
公司概况
公司名称:
HCW Biologics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
HCW Biologics Inc.于2018年4月2日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过中断慢性、低度炎症和与年龄相关的疾病之间的联系来延长健康跨度。该公司认为,与年龄相关的慢性低度炎症或“炎症”是导致几种疾病和状况的重要因素,例如癌症、心血管疾病、糖尿病、神经退行性疾病和自身免疫性疾病。
发行价格:
--
{"stockData":{"symbol":"HCWB","market":"US","secType":"STK","nameCN":"HCW Biologics Inc.","latestPrice":4.79,"timestamp":1752696000000,"preClose":4.36,"halted":0,"volume":32304,"hourTrading":{"tag":"盘后","latestPrice":4.5,"preClose":4.79,"latestTime":"19:22 EDT","volume":1277,"amount":5767.6901,"timestamp":1752708160562},"delay":0,"floatShares":964467,"shares":1597200,"eps":-30.95797,"marketStatus":"已收盘","change":0.43,"latestTime":"07-16 16:00:00 EDT","open":4.36,"high":4.79,"low":4.3,"amount":146557.9081488,"amplitude":0.112385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-30.95797,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":5,"adr":0,"listingDate":1626753600000,"exchange":"NASDAQ","adjPreClose":4.36,"preHourTrading":{"tag":"盘前","latestPrice":4.2572,"preClose":4.36,"latestTime":"09:04 EDT","volume":258,"amount":1086.8139059999999,"timestamp":1752671080725},"postHourTrading":{"tag":"盘后","latestPrice":4.5,"preClose":4.79,"latestTime":"19:22 EDT","volume":1277,"amount":5767.6901,"timestamp":1752708160562},"volumeRatio":1.10312},"requestUrl":"/m/hq/s/HCWB","defaultTab":"news","newsList":[{"id":"2552124918","title":"Hcw Biologics Inc.盘中异动 股价大涨6.29%报4.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552124918?lang=zh_cn&edition=full","pubTime":"2025-07-17 00:14","pubTimestamp":1752682441,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日00时14分,Hcw Biologics Inc.股票出现异动,股价大幅拉升6.29%。截至发稿,该股报4.63美元/股,成交量8765股,换手率0.35%,振幅5.20%。Hcw Biologics Inc.股票所在的生物技术行业中,整体涨幅为1.35%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717001401a44f1da9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717001401a44f1da9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2550650403","title":"Hcw Biologics Inc.盘中异动 大幅拉升6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650403?lang=zh_cn&edition=full","pubTime":"2025-07-10 02:51","pubTimestamp":1752087083,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日02时51分,Hcw Biologics Inc.股票出现波动,股价快速上涨6.31%。Hcw Biologics Inc.股票所在的生物技术行业中,整体涨幅为1.27%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710025123979ff7fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710025123979ff7fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2542503865","title":"Hcw Biologics Inc.6月11日成交额为12.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542503865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542503865?lang=zh_cn&edition=full","pubTime":"2025-06-12 10:17","pubTimestamp":1749694660,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日,Hcw Biologics Inc.成交额为12.34万美元,成交额较昨日减少50.15%,当日成交量为2.33万股。Hcw Biologics Inc.于2025年6月11日跌4.92%,报5.22美元,该股过去5个交易日跌14.98%,年初至今跌70.74%,过去60日跌61.5%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612101746a7046c29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612101746a7046c29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2542332016","title":"Hcw Biologics Inc.6月10日成交额为24.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542332016?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:09","pubTimestamp":1749607763,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日,Hcw Biologics Inc.成交额为24.75万美元,成交额较昨日增加31.22%,当日成交量为4.42万股。Hcw Biologics Inc.于2025年6月10日跌1.61%,报5.49美元,该股过去5个交易日跌18.06%,年初至今跌69.23%,过去60日跌59.63%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611100929a4a2bee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611100929a4a2bee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2542350659","title":"Hcw Biologics Inc.6月9日成交额为18.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542350659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542350659?lang=zh_cn&edition=full","pubTime":"2025-06-10 10:08","pubTimestamp":1749521286,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日,Hcw Biologics Inc.成交额为18.86万美元,成交额较昨日增加19.14%,当日成交量为3.25万股。Hcw Biologics Inc.于2025年6月9日跌7.62%,报5.58美元,该股过去5个交易日跌22.61%,年初至今跌68.72%,过去60日跌58.23%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100807a4a12f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100807a4a12f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2541885966","title":"Hcw Biologics Inc.6月5日成交额为27.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541885966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541885966?lang=zh_cn&edition=full","pubTime":"2025-06-06 10:07","pubTimestamp":1749175647,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日,Hcw Biologics Inc.成交额为27.34万美元,成交额较昨日减少65.23%,当日成交量为4.37万股。Hcw Biologics Inc.于2025年6月5日跌3.09%,报5.95美元,该股过去5个交易日跌25.81%,年初至今跌66.65%,过去60日跌57.38%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100731a6fc8b49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100731a6fc8b49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2541019254","title":"Hcw Biologics Inc.6月4日成交额为78.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541019254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541019254?lang=zh_cn&edition=full","pubTime":"2025-06-05 10:07","pubTimestamp":1749089235,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日,Hcw Biologics Inc.成交额为78.63万美元,成交额较昨日增加273.14%,当日成交量为12.50万股。Hcw Biologics Inc.于2025年6月4日跌8.36%,报6.14美元,该股过去5个交易日跌23.25%,年初至今跌65.58%,过去60日跌57.24%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605100720a6fb0589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605100720a6fb0589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2540828340","title":"Hcw Biologics Inc.6月3日成交额为21.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540828340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540828340?lang=zh_cn&edition=full","pubTime":"2025-06-04 10:07","pubTimestamp":1749002823,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日,Hcw Biologics Inc.成交额为21.07万美元,成交额较昨日增加15.10%,当日成交量为3.10万股。Hcw Biologics Inc.于2025年6月3日跌7.07%,报6.7美元,该股过去5个交易日跌16.25%,年初至今跌62.44%,过去60日跌54.11%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604100705a4991bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604100705a4991bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2540245710","title":"Hcw Biologics Inc.6月2日成交额为18.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540245710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540245710?lang=zh_cn&edition=full","pubTime":"2025-06-03 10:07","pubTimestamp":1748916420,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日,Hcw Biologics Inc.成交额为18.31万美元,成交额较昨日减少90.78%,当日成交量为2.49万股。Hcw Biologics Inc.于2025年6月2日跌6.73%,报7.21美元,该股过去5个交易日跌13.86%,年初至今跌59.59%,过去60日跌49.23%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603100711a49779ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603100711a49779ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2539201404","title":"Hcw Biologics Inc.5月30日成交额为198.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539201404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539201404?lang=zh_cn&edition=full","pubTime":"2025-05-31 10:05","pubTimestamp":1748657127,"startTime":"0","endTime":"0","summary":"美东时间2025年5月30日,Hcw Biologics Inc.成交额为198.69万美元,成交额较昨日增加320.87%,当日成交量为24.15万股。Hcw Biologics Inc.于2025年5月30日跌3.62%,报7.73美元,该股过去5个交易日跌6.98%,年初至今跌56.67%,过去60日跌42.99%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531100537a6f414c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531100537a6f414c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2539215878","title":"Hcw Biologics Inc.5月29日成交额为47.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539215878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539215878?lang=zh_cn&edition=full","pubTime":"2025-05-30 10:04","pubTimestamp":1748570698,"startTime":"0","endTime":"0","summary":"美东时间2025年5月29日,Hcw Biologics Inc.成交额为47.21万美元,成交额较昨日增加2.71%,当日成交量为5.89万股。Hcw Biologics Inc.于2025年5月29日涨0.25%,报8.02美元,该股过去5个交易日跌7.82%,年初至今跌55.04%,过去60日跌43.84%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530100459a4921813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530100459a4921813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2538414470","title":"Hcw Biologics Inc.5月27日成交额为84.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538414470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538414470?lang=zh_cn&edition=full","pubTime":"2025-05-28 10:08","pubTimestamp":1748398107,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日,Hcw Biologics Inc.成交额为84.07万美元,成交额较昨日增加32.66%,当日成交量为10.60万股。Hcw Biologics Inc.于2025年5月27日跌4.42%,报8.0美元,该股过去5个交易日跌6.65%,年初至今跌55.16%,过去60日跌47.37%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528100830a6efa0d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528100830a6efa0d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2537693941","title":"Hcw Biologics Inc.5月23日成交额为63.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537693941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537693941?lang=zh_cn&edition=full","pubTime":"2025-05-24 09:58","pubTimestamp":1748051904,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日,Hcw Biologics Inc.成交额为63.38万美元,成交额较昨日减少47.54%,当日成交量为7.66万股。Hcw Biologics Inc.于2025年5月23日涨0.72%,报8.37美元,该股过去5个交易日跌6.48%,年初至今跌53.08%,过去60日跌44.79%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524095826a6eae8e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524095826a6eae8e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2537153237","title":"Hcw Biologics Inc.2025财年第一财季实现净利润-2.20百万美元,同比增加70.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153237?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:01","pubTimestamp":1748016087,"startTime":"0","endTime":"0","summary":"5月24日,Hcw Biologics Inc.公布财报,公告显示公司2025财年第一财季净利润为-2.20百万美元,同比增加70.55%;其中营业收入为5065.00美元,同比减少99.55%,每股基本收益为-1.97美元。从资产负债表来看,Hcw Biologics Inc.总负债34.85百万美元,其中短期债务6.23百万美元,资产负债比为0.76,流动比率为0.07。机构评级:截至2025年5月24日,当前有1家机构对Hcw Biologics Inc.目标价做出预测,其中目标均价为120.00美元,其中最低目标价为120.00美元,最高目标价为120.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000232a489e625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000232a489e625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2537961516","title":"Hcw Biologics Inc.5月21日成交额为51.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537961516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537961516?lang=zh_cn&edition=full","pubTime":"2025-05-22 10:00","pubTimestamp":1747879222,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日,Hcw Biologics Inc.成交额为51.81万美元,成交额较昨日减少74.05%,当日成交量为5.86万股。Hcw Biologics Inc.于2025年5月21日跌5.23%,报8.7美元,该股过去5个交易日跌1.25%,年初至今跌51.23%,过去60日跌39.42%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522100028a6e823ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522100028a6e823ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2537067598","title":"Hcw Biologics Inc.5月20日成交额为199.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537067598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537067598?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:59","pubTimestamp":1747792749,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日,Hcw Biologics Inc.成交额为199.66万美元,成交额较昨日减少8.54%,当日成交量为22.51万股。Hcw Biologics Inc.于2025年5月20日涨7.12%,报9.18美元,该股过去5个交易日跌8.66%,年初至今跌48.54%,过去60日跌38.8%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521095910a6e6b5ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521095910a6e6b5ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2536864188","title":"Hcw Biologics Inc.盘中异动 大幅拉升5.13%报9.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536864188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536864188?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:24","pubTimestamp":1747754677,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时24分,Hcw Biologics Inc.股票出现异动,股价快速上涨5.13%。Hcw Biologics Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520232437975fab91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520232437975fab91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NRXS","BK4082","HCWB","BK4139"],"gpt_icon":0},{"id":"2536657727","title":"Hcw Biologics Inc.5月19日成交额为218.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536657727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536657727?lang=zh_cn&edition=full","pubTime":"2025-05-20 09:54","pubTimestamp":1747706056,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日,Hcw Biologics Inc.成交额为218.29万美元,成交额较昨日减少33.18%,当日成交量为24.90万股。Hcw Biologics Inc.于2025年5月19日跌4.25%,报8.57美元,该股过去5个交易日涨64.49%,年初至今跌51.96%,过去60日跌45.06%。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9218是一种双功能免疫疗法,具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520095419a6e56377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520095419a6e56377&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2536633252","title":"Hcw Biologics Inc.盘中异动 早盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536633252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536633252?lang=zh_cn&edition=full","pubTime":"2025-05-19 23:02","pubTimestamp":1747666931,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日23时02分,Hcw Biologics Inc.股票出现波动,股价快速跳水5.03%。Hcw Biologics Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519230212975e744f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519230212975e744f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2535731520","title":"Hcw Biologics Inc.盘中异动 早盘大幅上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535731520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535731520?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:49","pubTimestamp":1747403353,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时49分,Hcw Biologics Inc.股票出现波动,股价急速上涨5.37%。Hcw Biologics Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Hcw Biologics Inc.公司简介:HCW Biologics Inc是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过打破慢性低度炎症与与年龄相关疾病之间的联系,延长健康寿命。它已选择了两种分子作为其产品候选药物;HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞,从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214914a480fca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214914a480fca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hcwbiologics.com","stockEarnings":[{"period":"1week","weight":0.0583},{"period":"1month","weight":-0.2},{"period":"3month","weight":-0.4286},{"period":"6month","weight":-0.6959},{"period":"1year","weight":-0.8443},{"period":"ytd","weight":-0.7557}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HCW Biologics Inc.于2018年4月2日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,专注于发现和开发新型免疫疗法,通过中断慢性、低度炎症和与年龄相关的疾病之间的联系来延长健康跨度。该公司认为,与年龄相关的慢性低度炎症或“炎症”是导致几种疾病和状况的重要因素,例如癌症、心血管疾病、糖尿病、神经退行性疾病和自身免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.125505},{"month":2,"riseRate":0.75,"avgChangeRate":0.149026},{"month":3,"riseRate":0.5,"avgChangeRate":-0.010659},{"month":4,"riseRate":0.25,"avgChangeRate":-0.1522},{"month":5,"riseRate":0.25,"avgChangeRate":-0.089644},{"month":6,"riseRate":0.5,"avgChangeRate":-0.08481},{"month":7,"riseRate":0.5,"avgChangeRate":0.014788},{"month":8,"riseRate":0.25,"avgChangeRate":-0.119069},{"month":9,"riseRate":0.5,"avgChangeRate":-0.021114},{"month":10,"riseRate":0.25,"avgChangeRate":0.015666},{"month":11,"riseRate":0.25,"avgChangeRate":-0.169409},{"month":12,"riseRate":0.25,"avgChangeRate":-0.051277}],"exchange":"NASDAQ","name":"HCW Biologics Inc.","nameEN":"HCW Biologics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"HCW Biologics Inc.,HCWB,HCW Biologics Inc.股票,HCW Biologics Inc.股票老虎,HCW Biologics Inc.股票老虎国际,HCW Biologics Inc.行情,HCW Biologics Inc.股票行情,HCW Biologics Inc.股价,HCW Biologics Inc.股市,HCW Biologics Inc.股票价格,HCW Biologics Inc.股票交易,HCW Biologics Inc.股票购买,HCW Biologics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}